Nouscom Genetic Vaccine Encoding Shared Neoantigens to Treat Tumors with MicroSatellite Instability (MSI)

Time: 3:00 pm
day: Day One

Details:

  • Large neoantigen payload is ensured by Nouscom genetic vaccination platform
  • GAd/MVA heterologous prime/boost results in induction of CD8 T cells in preclinical models and cancer patients
  • T cells trafficking and expansion in the tumor is the key driver of treatment efficacy

Speakers:

Elisa Scarselli